Related Experiment Video
Updated: Oct 20, 2025

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
Published on: March 17, 2023
Singlet Oxygen "Afterglow" Therapy with NIR-II Fluorescent Molecules
Jianhua Zou1,2,3, Ling Li1,2,3, Jianwei Zhu4
1Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, 119074, Singapore.
This study introduces a novel boron dipyrromethene (BODIPY) dye, ABDPTPA, that enhances phototherapy by reversibly capturing and releasing singlet oxygen (1 O2 ) for prolonged "afterglow" and improved tumor treatment.
Area of Science:
- * Photochemistry and Photophysics
- * Materials Science
- * Nanomedicine and Cancer Therapy
Background:
- * Enhancing phototherapeutic efficacy requires strategies to prolong the lifespan of singlet oxygen (1 O2 ) particularly under dark and hypoxic conditions.
- * Heavy-atom-free photosensitizers are desirable for reduced toxicity in photodynamic therapy.
- * Boron dipyrromethene (BODIPY) dyes offer tunable photophysical properties for various applications.
Purpose of the Study:
- * To synthesize and evaluate anthracene-functionalized BODIPY dyes as efficient, heavy-atom-free photosensitizers for phototherapy.
- * To investigate the mechanism of reversible singlet oxygen (1 O2 ) capture and release for prolonged
- afterglow
- * To assess the in vitro and in vivo efficacy of the developed photosensitizer for cancer treatment.
Main Methods:
- * Synthesis of three BODIPY dyes, with a focus on anthracene-functionalized ABDPTPA.
- * Characterization of photophysical properties, including singlet oxygen (1 O2 ) quantum yield and lifetime measurements.
- * In vitro cytotoxicity assays on U87MG cells and in vivo near-infrared-II fluorescence imaging-guided phototherapy in a tumor model.
Main Results:
- * ABDPTPA demonstrated efficient spin-orbit charge-transfer intersystem crossing, yielding a high 1 O2 quantum yield (60%).
- * The anthracene moiety reversibly reacted with 1 O2 to form an endoperoxide, which upon light cessation, released 1 O2 via thermal cycloreversion, creating a prolonged 1 O2
- afterglow
- with a half-lifetime of 9.2 minutes.
- * ABDPTPA nanoparticles exhibited low cytotoxicity (IC50 = 3.6 µg mL-1 on U87MG cells) and effectively inhibited tumor proliferation in vivo with no observed side effects.
Conclusions:
- * Anthracene-functionalized BODIPY (ABDPTPA) serves as an efficient heavy-atom-free photosensitizer.
- * The developed 1 O2
- afterglow
- strategy significantly enhances phototherapeutic efficacy.
- * ABDPTPA nanoparticles show great promise for advanced phototheranostics, enabling complete tumor regression.
Related Concept Videos
Total Internal Reflection Fluorescence Microscopy
Photoluminescence: Applications
Fluorescence and Phosphorescence: Instrumentation
Photoluminescence: Fluorescence and Phosphorescence
A pair of electrons in a...

